EP2937083
Formulations, salts and polymorphs of transnorsertraline and uses thereof
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.12.2010EP published:
27.3.2019EP application number:
15150813.2
EPO information:
European Patent Register
Max expiry date:
2.12.2030
Title:
Formulations, salts and polymorphs of transnorsertraline and uses thereof
Timeline
Today
3.12.2010EP application
27.3.2019EP Publication
Owner
Name:
Sunovion Pharmaceuticals Inc.Address:
84 Waterford Drive, 01752, Marlborough, MA, US
Inventor
Name:
Laughlin, Sharon M.Address:
Marlborough, MA, US
Name:
Sizensky, Michael J.Address:
Marlborough, MA, US
Name:
Singh, Surendra P.Address:
Marlborough, MA, US
Name:
Wilkinson, Scott H.Address:
Marlborough, MA, US
Name:
Huang, Cai GuAddress:
Marlborough, MA, US
Name:
Bonasia, Philip JamesAddress:
Marlborough, MA, US
Name:
D'Souza, Susan S.Address:
Marlborough, MA, US
Priority
Number:
266864 PDate:
4.12.2009Country:
US
Classification
Categories:
A61K 31/135, A61K 31/70, A61P 25/00, A61K 9/20